SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-047894
Filing Date
2022-08-15
Accepted
2022-08-15 13:39:52
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_bioessence.htm   iXBRL 10-Q 573870
2 CERTIFICATION f10q0622ex31-1_bioessence.htm EX-31.1 15244
3 CERTIFICATION f10q0622ex31-2_bioessence.htm EX-31.2 14780
4 CERTIFICATION f10q0622ex32-1_bioessence.htm EX-32.1 6924
5 CERTIFICATION f10q0622ex32-2_bioessence.htm EX-32.2 7470
6 GRAPHIC image_001.jpg GRAPHIC 7168
  Complete submission text file 0001213900-22-047894.txt   4008470

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cik00001723059-20220630.xsd EX-101.SCH 69132
8 XBRL CALCULATION FILE cik00001723059-20220630_cal.xml EX-101.CAL 33264
9 XBRL DEFINITION FILE cik00001723059-20220630_def.xml EX-101.DEF 209003
10 XBRL LABEL FILE cik00001723059-20220630_lab.xml EX-101.LAB 457191
11 XBRL PRESENTATION FILE cik00001723059-20220630_pre.xml EX-101.PRE 213024
66 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_bioessence_htm.xml XML 416999
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 221164594
SIC: 2834 Pharmaceutical Preparations